A 32-week gestation male infant born to a 28-year-old primigravida mother is delivered via emergency cesarean section for fetal distress. The mother had no antenatal corticosteroids. At 2 hours of life, the infant develops tachypnea (respiratory rate 68/min), intercostal and subcostal retractions, nasal flaring, and a characteristic grunting sound. Chest X-ray shows a diffuse ground-glass appearance with air bronchograms and a low lung volume. Arterial blood gas shows pH 7.28, PaCO₂ 52 mmHg, PaO₂ 58 mmHg on FiO₂ 0.40. What is the most likely diagnosis?

Explanation

## Clinical Diagnosis: Respiratory Distress Syndrome (RDS) ### Key Clinical Features **Key Point:** RDS (also called Hyaline Membrane Disease) is the most common cause of respiratory distress in preterm infants, caused by deficiency of pulmonary surfactant. ### Pathophysiology 1. Surfactant production begins at ~24 weeks gestation but is insufficient until ~35 weeks 2. Lack of surfactant → increased alveolar surface tension → alveolar collapse (atelectasis) 3. Results in ventilation-perfusion mismatch, hypoxemia, and hypercarbia 4. Collapsed alveoli appear as ground-glass on CXR; air bronchograms visible in patent airways ### Diagnostic Criteria in This Case | Feature | Finding | Significance | |---------|---------|---------------| | **Gestational age** | 32 weeks | High-risk period; surfactant insufficient | | **Absence of steroids** | No antenatal corticosteroids | Missed opportunity to accelerate fetal lung maturity | | **Timing** | Symptoms at 2 hours of life | Classic early presentation | | **Clinical signs** | Tachypnea, retractions, grunting | Compensatory effort to maintain FRC | | **CXR pattern** | Ground-glass + air bronchograms | Pathognomonic for RDS | | **Blood gas** | Respiratory acidosis (pH 7.28, PaCO₂ 52) | Indicates inadequate ventilation | **High-Yield:** The combination of **prematurity + absent steroids + ground-glass CXR + early respiratory distress** is diagnostic of RDS. ### Grunting Mechanism **Clinical Pearl:** Grunting is an attempt to maintain positive end-expiratory pressure (PEEP) by partial glottic closure, preventing alveolar collapse at end-expiration. ### Management Approach ```mermaid flowchart TD A[Preterm infant with RDS]:::outcome --> B[Antenatal steroids given?]:::decision B -->|Yes| C[Fetal lung maturity enhanced]:::action B -->|No| D[Increased severity expected]:::action A --> E[Postnatal management]:::action E --> F[Exogenous surfactant replacement]:::action E --> G[Respiratory support CPAP/mechanical ventilation]:::action E --> H[Supportive care oxygen, fluids, monitoring]:::action F --> I[Rapid improvement in compliance]:::outcome ``` **Key Point:** Exogenous surfactant (e.g., poractant alfa, beractant) is the definitive treatment and dramatically improves outcomes in RDS. [cite:Nelson Textbook of Pediatrics 21e Ch 102]